Provided by Tiger Fintech (Singapore) Pte. Ltd.

CHINARES PHARMA

4.920
+0.000
Volume:8.19M
Turnover:40.24M
Market Cap:30.91B
PE:8.69
High:4.950
Open:4.910
Low:4.880
Close:4.920
Loading ...

China Resources Pharmaceutical - Qtrly Net Profit for Tasly Pharmaceuticals RMB332.1 Mln

THOMSON REUTERS
·
Yesterday

Jiang Zhong Pharmaceutical's Q1 Profit Increases

MT Newswires Live
·
Yesterday

BRIEF-China Resources Pharmaceutical Says QTRLY Net Profit Rmb425.0 Million For Dong-E-E-Jiao

Reuters
·
Yesterday

China Resources Pharmaceutical - Qtrly Net Profit of Jiangzhong Pharmaceutical RMB306.7 Mln

THOMSON REUTERS
·
Yesterday

China Resources Pharmaceutical - Qtrly REV of Jiangzhong Pharmaceutical RMB1.18 Bln

THOMSON REUTERS
·
Yesterday

China Resources Pharma Unit Issues 400 Million Yuan of Bonds

MT Newswires Live
·
25 Apr

BRIEF-China Resources Pharmaceutical Posts Qtrly Results For China Resources Boya Bio-Pharmaceutical

Reuters
·
25 Apr

China Resources Pharmaceutical - Qtrly Net Profit for China Resources Boya Bio-Pharmaceutical RMB139.3 Mln

THOMSON REUTERS
·
25 Apr

Stock Track | China Resources Pharmaceutical Plummets 5.13% Following Disappointing 2024 Profit Results

Stock Track
·
26 Mar

China Resources Pharmaceutical's 2024 Profit Slides; Shares Fall 4%

MT Newswires Live
·
26 Mar

BRIEF-China Resources Pharmaceutical Says FY Net Profit Attributable For Jiangzhong Pharmaceutical Was RMB788.2 Million

Reuters
·
19 Mar

China Resources Pharmaceutical - Cash Dividend of RMB7.00 for Every 10 Shares of Jiangzhong Pharmaceutical

THOMSON REUTERS
·
19 Mar

BRIEF-China Resources Pharmaceutical Posts FY Results For CR Double-Crane Pharmaceutical

Reuters
·
19 Mar

China Resources Pharmaceutical - FY Net Profit Attributable for China Resources Double-Crane Pharmaceutical RMB1.63 Bln

THOMSON REUTERS
·
19 Mar

China Resources Pharmaceutical Posts FY Net Profit Attributable Of CR Boya Bio-Pharmaceutical Of RMB397 Million

Reuters
·
18 Mar

China Resources Pharmaceutical - FY Net Profit Attributable of Cr Boya Bio-Pharmaceutical RMB397 Mln

THOMSON REUTERS
·
18 Mar

China Resources Pharmaceutical Posts FY Revenue RMB5.92 Bln For Dong-E-E-Jiao

Reuters
·
18 Mar

China Resources Pharmaceutical - FY Net Profit Attributable for Dong-E-E-Jiao RMB1.56 Bln

THOMSON REUTERS
·
17 Mar

CR Sanjiu Logs 18% Boost in 2024 Profit

MT Newswires Live
·
13 Mar

KPC Pharmaceuticals' 2024 Profit Rises 20%

MT Newswires Live
·
12 Mar